|
| Protein Name | Heat Shock 70 kDa Protein 1A (Hsp70-1A) |
| Gene | [HSPA1A](/genes/hspa1a) |
| UniProt | P0DMV8 |
| Molecular Weight | ~70 kDa |
| Subcellular Localization | Cytoplasm, Nucleus, Cell membrane |
| Protein Family | Hsp70 family |
| Aliases | HSP70-1A, HSP70, HSPA1A, Hsp70 |
HSPA1A (Heat Shock 70 kDa Protein 1A), also known as Hsp70-1A, is the prototypical stress-inducible molecular chaperone encoded by the HSPA1A gene. As one of the most studied heat shock proteins, HSPA1A plays essential roles in protein homeostasis, cellular stress protection, and cell survival. It is dramatically upregulated in response to various stresses including heat, oxidative stress, and proteotoxic challenges. HSPA1A has emerged as a critical protein in neurodegenerative disease research due to its ability to prevent and clear toxic protein aggregates [1].
HSPA1A has the canonical Hsp70 domain architecture:
¶ N-terminal ATPase Domain (~44 kDa)
- Binds and hydrolyzes ATP
- Regulates substrate binding cycle
- Contains the characteristic Walker A and B motifs
¶ Substrate-binding Domain (~25 kDa)
- Peptide-binding cavity with lid structure
- Binds hydrophobic peptide segments
- EEVD motif at C-terminus for co-chaperone binding
¶ Interdomain Linker
- Connects ATPase and substrate-binding domains
- Allosterically couples ATP hydrolysis to substrate binding
HSPA1A performs ATP-dependent protein folding:
- Substrate recognition: Binds hydrophobic regions of unfolded proteins
- Folding assistance: Facilitates proper protein folding
- Aggregation prevention: Prevents toxic protein aggregate formation
- Refolding: Can rescue denatured proteins
As the major stress-inducible Hsp70:
- Heat shock response: Primary effector of HSF1 activation
- Oxidative stress protection: Counteracts ROS-induced damage
- Proteotoxic stress: Manages misfolded protein accumulation
HSPA1A is central to cellular proteostasis:
- Ubiquitin-proteasome system: Co-operates with E3 ubiquitin ligases
- Autophagy: Regulates aggrephagy and mitophagy
- Protein triage: Decides between refolding, degradation, or sequestration
HSPA1A has well-characterized anti-apoptotic effects:
- Inhibits caspase activation
- Blocks apoptosome formation
- Stabilizes anti-apoptotic proteins
HSPA1A plays multiple protective roles in AD:
Amyloid-β management:
- Binds to Aβ peptides, preventing aggregation [2]
- Facilitates Aβ clearance via proteasome and autophagy
- Protects neurons from Aβ-induced toxicity
Tau pathology:
- Interacts with hyperphosphorylated tau
- Facilitates tau clearance
- Protects against tau-induced neurodegeneration
Neuroprotection:
- Anti-apoptotic functions
- Oxidative stress mitigation
- Mitochondrial protection
HSPA1A is particularly important in PD:
α-Synuclein handling:
- Binds to alpha-synuclein monomers and oligomers [3]
- Inhibits α-synuclein fibrillization
- Facilitates autophagic clearance of α-synuclein aggregates
Mitochondrial function:
- Protects against mitochondrial toxins (e.g., MPTP, 6-OHDA)
- Maintains mitochondrial protein quality
- Supports mitophagy
Dopaminergic neuron survival:
- Specifically protects dopaminergic neurons
- Upregulated in PD brains (compensatory response)
In ALS:
- Handles mutant SOD1 aggregates
- Involved in stress granule dynamics
- Motor neuron protection
In Huntington's disease:
- Binds to mutant huntingtin Huntingtin [4]
- Reduces polyglutamine aggregation
- Improves neuronal survival in models
HSPA1A is a major therapeutic target:
Small molecules that increase HSPA1B expression:
- Geranylgeranylacetone (GGA): Induces HSPA1A expression
- Arimoclomol: HSP co-inducer in clinical trials for ALS
- 17-DMAG: HSP90 inhibitor (indirect HSPA1A inducer)
- AAV-mediated HSPA1A delivery to brain
- Viral vector-based approaches
- Recombinant Hsp70 administration
- Cell-permeable Hsp70 variants
Key developments:
- HSPA1A is consistently upregulated in neurodegenerative disease brains
- Genetic variants of HSPA1A modify disease risk and progression
- HSPA1A-based therapies show promise in preclinical models